It has long been known that the retina can be harmed by bright light and that it is important to understand the limits and mechanisms of retinal phototoxicity to incorporate safe practices of retinal light exposures. In particular, phototoxicity is important because several clinical procedures (such as slit-lamp examination, fundus photography, fluorescein angiography, and retinal surgery) are often performed at light levels close to the limits imposed by current safety standards.
1–3 In addition, those procedures are used to examine retinas affected by eye diseases, and the extent to which patients have increased susceptibility to light-induced retinal damage remains unknown. Indeed, it has been shown that certain genetic mutations can cause higher susceptibility to light in animal models,
4 and that phototoxicity increases with age, even in the normal human retina,
5 as is observed by the accumulation of lipofuscin in the retinal pigment epithelial (RPE) cells.
6 Previous studies have shown that A2E, a primary component of lipofuscin, is one of the phototoxic materials in the retina. In cultured ARPE-19 cells, the combination of A2E and blue light resulted in cell death
7 by a photooxidative mechanism.
8 The role of phototoxicity and photooxidation in the retina has led to the theory that light exposure plays a role in some retinal diseases including age-related macular degeneration,
5,9–12 although this association is controversial.
13,14 Regardless, until phototoxic mechanisms are fully understood, studies of retinal toxicity remain important for the implementation of safe practices in ophthalmic procedures such as retinal surgery and ophthalmic imaging applications including fundus photography, fluorescein angiography, and lipofuscin autofluorescence imaging.